EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study

Seyma Nur Erol, Selda Pelin Kartal

Acta Dermato-Venereologica · 16.09.2025 · 105 · adv44624

DOI: 10.2340/actadv.v105.44624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 16.09.2025. Verfasst von Seyma Nur Erol und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Ankara Etlik City Hospital, Ankara, Turkey. erolseymanur@gmail.com. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Ankara Etlik City Hospital, Ankara, Turkey. erolseymanur@gmail.com.
  • Department of Dermatology and Venereology, Ankara Etlik City Hospital, Ankara, Turkey.

Zitieren

APA

Erol, S. N., & Kartal, S. P. (2025). Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study. Acta Dermato-Venereologica, 105, adv44624. https://doi.org/10.2340/actadv.v105.44624

Vancouver

Erol SN, Kartal SP. Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study. Acta Dermato-Venereologica. 2025;105:adv44624. doi:10.2340/actadv.v105.44624

BibTeX
@article{Erol2025,
  author = {Erol, Seyma Nur and Kartal, Selda Pelin},
  title = {Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  volume = {105},
  pages = {adv44624},
  doi = {10.2340/actadv.v105.44624}
}
Kostenlos starten →